Tweenvest Stocks

Evopoint Biosciences Co., Ltd. (SHSE: 688837)

Health Care · Biotechnology · CN

CN¥49.40

0.00% today · +22.9% 1Y

Evopoint Biosciences Co., Ltd. (SHSE: 688837) operates in the Biotechnology industry within the Health Care sector. The company is valued at $3.21B and employs 362 people.

Over the last twelve months the share price has gained 22.9%, trading between 39.12 and 78.98.

Tweenvest scores Evopoint Biosciences Co., Ltd. across four factors: quality 69/100, value 15/100. Its strongest factor is quality.

688837 price history

Not enough price history to draw a chart yet.

Key figures

Market cap
$3.21B
Revenue (TTM)
$163.56M
P/E
44.71
EPS
1.11
Dividend yield
—
Beta (5Y)
—
52-week high
CN¥78.98
52-week low
CN¥39.12
Avg volume (3M)
—
Shares outstanding
435.49M
Employees
362
Next earnings
—

About Evopoint Biosciences Co., Ltd.

Evopoint Biosciences Co., Ltd. operates as a biopharmaceutical company that offers therapies for patients with oncology and multidrug-resistant infections. The company's three core technology platforms are a Small Molecule Drug Discovery Platform, a Novel Antibody Discovery Platform, and a Targeted Protein Degradation Platform. Several of its pipeline products have advanced to Phase III clinical trials or the New Drug Application stage.

Founded
2017
Listed since
Sep 16, 2026
Exchange
Shanghai Stock Exchange
Currency
CNY
CompanyMarket capPriceDay
Walvax Biotechnology Co., Ltd.SZSE: 300142$3.39BCN¥14.23+4.79%
Acadia Pharmaceuticals Inc.NasdaqGS: ACAD$3.39B$19.46-0.99%
Viking Therapeutics, Inc.NasdaqCM: VKTX$3.33B$28.41-0.47%
CareDx, Inc.NasdaqGM: CDNA$3.26B$62.94-0.16%
Xiamen Amoytop Biotech Co., Ltd.SHSE: 688278$3.13BCN¥52.89+2.90%
Arcus Biosciences, Inc.NYSE: RCUS$3.12B$24.52+0.99%
Denali Therapeutics Inc.NasdaqGS: DNLI$3.06B$19.00-0.84%
Precigen, Inc.NasdaqGS: PGEN$3.06B$7.50-12.18%

Browse every Biotechnology company →

Figures last refreshed Oct 4, 2026.